Compare LFMD & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFMD | NUS |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 266.5M |
| IPO Year | 2012 | 1996 |
| Metric | LFMD | NUS |
|---|---|---|
| Price | $3.29 | $4.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.14 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 558.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | 141.67 | ★ 207.80 |
| EPS | ★ N/A | N/A |
| Revenue | $12,468,578.00 | ★ $3,176,718,000.00 |
| Revenue This Year | $17.52 | N/A |
| Revenue Next Year | $18.73 | $7.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 49.79 | 48.98 |
| 52 Week Low | $2.60 | $4.49 |
| 52 Week High | $7.32 | $14.62 |
| Indicator | LFMD | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 38.71 |
| Support Level | $3.00 | $4.49 |
| Resistance Level | $3.41 | $5.51 |
| Average True Range (ATR) | 0.25 | 0.24 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 28.92 | 21.29 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.